Accurate biomarkers for predicting COVID‐19 severity have remained an unmet need due to
an incomplete understanding of virus pathogenesis and heterogeneity among patients …

Purpose Our aim was to quantify the mortality from COVID-19 and identify any interactions
with frailty and other demographic factors. Methods Hospitalised patients aged≥ 70 were …

The death toll of the current COVID-19 pandemic is strongly biased toward the elderly.
COVID-19 case fatality rate (CFR) increases with age exponentially, its doubling time being …

Background Coronavirus disease 2019 (COVID-19)-induced mortality occurs predominantly
in older patients. Several immunomodulating therapies seem less beneficial in these …

Background The identification of coronavirus disease 2019 (COVID-19) risk factors is
requested to implement prevention strategies. Aim To explore the associations between the …

As the global coronavirus disease-19 (COVID-19) pandemic caused by severe acute
respiratory distress syndrome coronavirus 2 continues to cause higher mortality and …

Since the outbreak, COVID-19 has spread rapidly across the globe due to its high infectivity
and lethality. Age appears to be one of the key factors influencing the status and progression …

Background The aim of this study was to describe outcomes in hospitalised older people
with different levels of frailty and COVID-19 infection. Methods We undertook a single-centre …

Abstract Background/Objectives Frailty has been linked to increased risk of COVID‐19
mortality, but evidence is mainly limited to hospitalized older individuals. This study aimed to …

While the full impact of COVID-19 is not yet clear, early studies have indicated that upwards
of 10% of patients experience COVID-19 symptoms longer than 3 weeks, known as Long …